Wednesday, September 14, 2016

MTOR inhibitors


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell growth and angiogenesis. In certain cancers the mTOR pathway is more active.


Mammalian target of rapamycin (mTOR) inhibitors are used in treatment of renal cancer and is being studied for use in other types of cancers. More benefits are being seen when MTOR inhibitors are combined with other chemotherapy agents.

See also

Medical conditions associated with mTOR inhibitors:

  • Brain Tumor
  • Breast Cancer
  • Organ Transplant, Rejection Prophylaxis
  • Pancreatic Cancer
  • Renal Cell Carcinoma

Drug List:

No comments:

Post a Comment